Everfront Biotech Holding Company Limited (EFB)

Everfront Biotech Holding Company will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

EFB Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2023	FY 2022
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Revenue	0	-	0.08
Revenue Growth	-	-	-
Gross Profit	0	-	0.08
Operating Income	-2.19	-2.39	-1.7
Net Income	-2.13	-2.29	-1.49

Fiscal Year	Current	FY 2023	FY 2022
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Investments	0.43	1.23	0.55
Total Debt	2.53	2.53	0.01
Net Cash (Debt)	-2.1	-1.3	0.54
Net Cash Growth	-	-	-

Fiscal Year	TTM	FY 2023	FY 2022
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Operating Cash Flow	-1.87	-2.28	-1.92
Capital Expenditures	-0	-0.03	-
Free Cash Flow	-1.87	-2.31	-1.92
Free Cash Flow Growth	-	-	-

Fiscal Year	TTM	FY 2023	FY 2022
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Gross Margin	-	-	100.00%
Operating Margin	-	-	-2132.44%
Pretax Margin	-	-	-1870.30%
Profit Margin	-	-	-1870.30%
FCF Margin	-	-	-2407.77%